Lexion Medical

What Lexion Medical does

Lexion Medical is a privately held U.S. medical device manufacturer founded in 2000 and headquartered in St. Paul, Minnesota, with 51-100 employees. The company designs and manufactures advanced gas-conditioning and pneumo-management technologies used during minimally invasive (laparoscopic and robotic) surgical procedures. Its core technology stack centers on real-time intra-cavitary pressure and flow sensing, CO2 heating and humidification, ULPA filtration for surgical plume, and proprietary trocar gas-flow architecture, all wrapped into the LEXION 3-in-1 System that combines insufflation, smoke evacuation, and gas conditioning in a single capital platform.

The product portfolio is anchored by the AP 50/30 Intelligent Insufflator (the central capital device), supported by the InsuflowPort line of gas-conditioning tubing/trocars in multiple sizes and bariatric lengths, the PneuView XE active disposable smoke eliminator, and the original Insu*flow gas conditioner for shorter cases. Trademark assets (Insu*flow®, InsuflowPort®, PneuVIEW®) reflect early-mover brand position in the gas-conditioning category. The company self-describes as the pioneer and "world leader" in gas conditioning technology and positions itself as a cost-effective alternative to dominant competitors such as AirSeal.

Lexion operates a direct enterprise field-sales motion via medical-device representatives offering free consultations and trials to hospitals, ambulatory surgery centers, and surgical specialty practices. The revenue model is two-stream: (1) one-time capital equipment sales of the AP 50/30 insufflator, and (2) recurring per-procedure revenue from single-use disposable devices (InsuflowPort tubing and PneuView XE smoke eliminators). Pricing is quote-based, contracts are multi-year, and the customer base is distributed across surgical departments rather than concentrated in a single anchor account, with global reach indicated by an international partner portal.

Name

Lexion Medical

Legal name

Lexion Medical

Website

https://lexionmedical.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

Lexion Medical is a privately held U.S. medical device company (founded 2000, St. Paul, MN) that designs and manufactures the LEXION 3-in-1 pneumo-management system — combining insufflation, smoke evacuation, and gas conditioning — sold to hospitals and surgical centers performing laparoscopic and robotic procedures.

Ownership category

akta.pro rank

Product category

Surgical Insufflation and Gas Conditioning Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers) (HLAHAGAK)

akta.pro secondary industries

Suction, Irrigation & Fluid Management Systems (HLAHADAK), Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)

Keywords

• Surgical insufflation systems
• Laparoscopic gas conditioning
• Surgical smoke evacuation
• Pneumoperitoneum management devices
• Minimally invasive surgery equipment

Headquarters

HQ city

Saint Paul

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Capital Equipment Sales (AP 50/30 Insufflator): The AP 50/30 intelligent insufflator is sold as capital equipment to hospitals and surgical centers. This represents a one-time hardware purchase for the surgical suite.
2. Disposable Medical Devices: Single-use disposable products including InsuflowPort tubing sets and PneuView XE smoke eliminating disposables are sold on a per-procedure basis, creating recurring revenue from existing customer installations.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Lexion Medical designs, manufactures, and sells advanced insufflation and gas conditioning devices for minimally invasive (laparoscopic and robotic) surgery. Its core offering is the LEXION System, a 3-in-1 platform that combines pneumostability (via the AP 50/30 Intelligent Insufflator), smoke evacuation (via the PneuView XE), and advanced gas conditioning (via the InsuflowPort and Insu*flow disposable tubing and trocars).

Product overview

Lexion Medical offers a unified 3-in-1 platform called the LEXION System for gas conditioning in minimally invasive surgical procedures. The system combines three core capabilities: Pneumostability (delivered via the AP 50/30 Intelligent Insufflator), Smoke Evacuation (via the PneuView XE Smoke Evacuation System), and Advanced Gas Conditioning (via InsuflowPort disposable tubing/trocar or Insu*flow conditioning device). The portfolio includes the AP 50/30 as the central intelligent insufflator with real-time pressure and flow sensing, the PneuView XE active smoke eliminator with ULPA filtration, and the InsuflowPort gas conditioning trocar available in multiple sizes. The company positions InsuflowPort as the higher-performance option for full procedures while Insu*flow serves shorter cases.

Differentiator

Problem solved

Functional benefit

Brands

• Insu*flow®: The Original Gas Conditioner - heated and humidified CO2 delivery device for laparoscopic surgery
• InsuflowPort®
• PneuView® XE
• AP 50/30

Quantifiable outcome

• Removes up to 15 Liters per minute of surgical plume while maintaining pneumoperitoneum
• +4 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Olympus: Olympus supplies insufflators and laparoscopic equipment to the same surgical departments Lexion targets. While broader in scope (endoscopy, imaging, capital stacks), Olympus is a comparable supplier of CO2 insufflation equipment and gas management accessories used in MIS procedures.
• Medtronic: Medtronic offers insufflation, smoke evacuation, and advanced energy products for laparoscopic and robotic surgery. It competes with Lexion in the same hospital GPO contracts but as a small slice of a much larger diversified surgical portfolio.
• Stryker: Stryker is a large diversified surgical equipment incumbent offering insufflators, smoke evacuation (e.g., Neptune, SafeAir), and integrated OR solutions. It competes with Lexion in the same hospital capital and disposable channels but as part of a much broader portfolio.
• Karl Storz: Karl Storz is a leading manufacturer of endoscopic, insufflation, and laparoscopic surgical instruments. Its insufflator and trocar product lines compete with Lexion's AP 50/30 and InsuflowPort, particularly in hospitals that standardize on Karl Storz towers.
• Ethicon (Johnson & Johnson): Ethicon supplies surgical devices including advanced energy, trocars, and accessories used in laparoscopic procedures. While not a direct insufflator competitor, it competes in the same surgical suite budgets and increasingly bundles smoke-management offerings.

Direct peers

• ERBE Elektromedizin: ERBE is a specialist in electrosurgery and smoke evacuation products. Its surgical smoke evacuators and gas management solutions compete directly with Lexion's PneuView XE in the OR smoke evacuation category.
• Conmed (Airseal): Conmed's Airseal insufflation system is the named direct competitor in Lexion's own customer testimonials. Both companies sell integrated insufflation/smoke-evacuation platforms to laparoscopic and robotic surgery departments, competing head-to-head on performance, price, and hospital contracts.

Others

• Intuitive Surgical: Intuitive Surgical's da Vinci robotic surgery platform is a downstream customer of insufflation technology — robotic MIS procedures require stable pneumo and smoke evacuation. Lexion's AP 50/30 and PneuView XE are positioned as accessories compatible with robotic platforms like da Vinci.

Emerging players

• Megadyne (J&J): Megadyne, now part of Ethicon/J&J, develops electrosurgical products and smoke evacuation pencils for laparoscopic surgery. It overlaps with Lexion in surgical plume management, particularly as a competitor to PneuView XE in OR smoke evacuation.
• Palliare: Palliare is a smaller specialist developing insufflation and smoke evacuation technology for laparoscopic and robotic surgery. It is a niche emerging competitor with overlapping product focus on stable pneumo and OR safety in MIS procedures.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/lexionmedical

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lexion Medical